Retinal vein occlusion and how it’s treated

Written in association with: Mrs Kapka Nenova
Published:
Edited by: Karolyn Judge

Retinal vein occlusion, or RVO, is treatable. But what’s involved? We speak to renowned consultant ophthalmologist Mrs Kapka Nenova all about this, alongside it’s severity, risk factors and the symptoms.

 

Person having their eye examined for RVO

 

What is RVO?

Retinal vein occlusion (RVO) is partial or total blockage of the central retinal vein, that provides oxygen and blood supply to the retina. More often it's just blockage of one or more branches and is called branch retinal vein occlusion (BRVO).

 

 

How serious is RVO?

The severity of RVO can vary from asymptomatic to severe loss of vision. When small peripheral branches are involved and the macula is not affected the condition may remain asymptomatic and undiagnosed.

 

When the bigger branches or the central vein are blocked, that results in a mild to severe loss of vision with permanent visual field defect. That is particularly the case when the centre of the retina called macula is affected.

 

 

What are the risk factors of RVO?

You can have a RVO without any obvious risk factors present.

 

People with systemic conditions like diabetes, hypertension, high cholesterol, cardiovascular disease, atherosclerosis, glaucoma, etc, are at higher risk of developing RVO, due to damage of the internal wall or narrowing of their blood vessels.

 

Having a control of the systemic conditions significantly reduces the risk of developing RVO.

 

 

What are the symptoms of RVO? When should you see a doctor?

Typically, the RVO is causing a sudden deterioration or loss of vision. Sometimes it remains unnoticed as the better eye is compensating and it’s found accidentally.

 

The sooner you see an ophthalmologist, the better chance your vision has to recover with the proposed treatment.

 

With small branch RVO you can have full spontaneous recovery of the vision without treatment, but observation is required.

 

 

Can RVO be cured? How is it treated?

The success of RVO treatment depends on the severity of the damage. Most of the time the treatment will achieve stabilisation of the condition and no further loss of vision.

 

It’s unlikely there will be late complications and poor response to the treatment resulting in further loss of vision. Despite the treatment there will be always a visual field defect that may or may not affect your vision.

 

There are different protocols for treatment with anti-VGF or steroid drugs administered with injection into the vitreous cavity. The effectiveness of these treatments has been proved in clinical trials and in practice over the last 10 years.

 

Laser treatment is not the first line of treatment and is used with debatable effect in more severe cases, not responding to the treatment with injections.

 

To get the best outcome with RVO treatment, you need to seek advice from an MR specialist as soon as the diagnosis is made.

 

 

 

If you require treatment for RVO or other ophthalmological conditions, arrange an appointment with Mrs Nenova via her Top Doctors profile.   

By Mrs Kapka Nenova
Ophthalmology

Mrs Kapka Nenova is a renowned consultant ophthalmologist who practises in East Grinstead. She has over 30 years of medical experience and specialises in medical retina conditions, retinal laser treatment, macular degeneration, vein occlusion, diabetic retinopathy, and uveitis.  

In 1992, Mrs Nenova graduated from the esteemed Medical University of Varna in Bulgaria and finalised her ophthalmology training at the Medical University of Sofia, Bulgaria. She worked as a consultant ophthalmologist in Bulgaria for 10 years before relocating to England. Since 2010 she has worked as a consultant ophthalmologist for the NHS. Additionally, Mrs Nenova completed both a fellowship of orbital and oculoplastic surgery at the Naples Medical University, Italy and a fellowship of medical retina at the Royal Victoria Infirmary, Newcastle upon Tyne, UK.   

Mrs Nenova has participated in numerous international trials, that aim to improve the efficiency of the latest treatments for medical retina conditions. These trials’ findings have been published in a high-impact ophthalmological journal. She is a clinical and educational supervisor for the Kent, Surrey, and Sussex regions and trains junior ophthalmologists.  
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Microdermoabrasion
    Microneedling
    Dark circles
    Mesotherapy
    Facelift
    Neck lift
    Botulinum toxin (Botox™)
    Dermal fillers
    Peeling
    Facial paralysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.